Arbuthnot Banking Group: 2020 results in line; 2021 outlook: strong recovery

Hardman & Co

The key highlights from Arbuthnot Banking Group plc (LON:ARBB) FY’20 results were a small loss (as expected), with breakeven excluding deal costs. Margin pressure (from base-rate cuts) and a £2m rise in impairments, despite there being zero higher-risk Stage 2/3 property exposures over 80% LTV (2019 over £30m), were the main drivers. The 2021 outlook is for i) a strong recovery, driven by loan volume growth, ii) less pain from excess liquidity, iii) profits generated by Asset Alliance after acquisition (completed end-March, which will also see a £10m equity uplift, as it is being bought below book), iv) a gain on the sale of Tay mortgages, v) forecast lower impairments, and vi) a dividend from STB.

  • Strategic opportunity: ABG has surplus capital (£84m) and deposits (£777m). This is the key to its positive medium-term outlook, as it can take the opportunities brought about by market disruption for organic and inorganic growth. Bank appetite to lend in niche sectors, and to non-bank finance companies, is muted.
  • Results in more detail: The loss before tax was £1.1m (2019: profit £7.0m); excluding acquisition costs, the business broke even in 2020. Operating income was steady at £72.5m (2019: £72.5m). Costs rose 2%. Bad debts rose by £2m to £2.8m. Loans fell 1% to £1.6bn. Deposits rose 13% to £2.4bn. AUM rose 4%.
  • Valuation: Our forecast scenarios and multiple valuation approaches see a broad range of valuations: 1,027p (Dividend Discount Model) to 1,896p (Gordon Growth Model); we have rolled forward our forecast year to 2022, resulting in a modest rise in the latter. The share price is 68% of the NAV.
  • Risks: Going forward, the key risk is credit. Historically, ABG has been very conservative in lending criteria and security taken. Its financial strength means that ABG can take time to optimise recoveries. Other risks include reputation, regulation and compliance.
  • Investment summary: Arbuthnot Banking Group offers strong-franchise and continuing-business (normalised) profit growth. Its balance sheet strength gives it a number of wide-ranging options to develop organic and inorganic opportunities. The latter are likely to increase in uncertain times. Management has been innovative, but also very conservative, in managing risk. Having a profitable, well-funded, well-capitalised and strongly growing bank priced below book value is an anomaly.

DOWNLOAD THE FULL REPORT

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Higher bond yields sharpen the focus on AI and asset allocation

Higher bond yields and a shift towards AI software are changing market positioning as investors weigh resilient growth against persistent inflation and debt supply.

Shakespeare Monofilament acquisition secures £5.92m asset-based funding package

Nova Capital Management’s acquisition of Shakespeare Monofilament UK is supported by a £5.92 million asset-based lending package spanning receivables, inventory, machinery and property.

Arbuthnot Latham launches cross-border investment service for US-connected UK clients

Arbuthnot Latham has launched Global Direct Service for US-connected UK clients, adding a direct-investment option to its private banking and wealth management offering.

AI spending comes under pressure as markets demand clearer returns

Markets are shifting their focus from the scale of AI spending to the returns it can generate as interest rates and competition remain key risks.

Arbuthnot Banking Group reports record deposits and wealth assets (LON:ARBB)

Hardman & Co analyst Mark Thomas discusses Arbuthnot Banking Group’s first-half 2026 results, highlighting record client balances, strong growth across deposits, wealth management and specialist lending, and the potential benefit of higher-for-longer interest rates.

Nova Capital backs Shakespeare Monofilament acquisition with £5.92m funding package

Nova Capital’s acquisition gives Shakespeare new ownership and a £5.92 million funding structure designed to support working capital and future development.

Search